Navigation Links
ForteBio Introduces BLItz™, a Revolutionary, Micro-volume Label-free Analysis Platform for Personal Assays

SAN DIEGO, Dec. 5, 2011 /PRNewswire/ -- ForteBio®, Inc., a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, today announced the launch of BLItz™, a revolutionary new platform that will enable scientists – for the first time – to conduct label-free analyses of proteins using small sample volumes easily and cost-efficiently at their lab bench. The new platform was unveiled today at the IBC Antibody Engineering and Therapeutics Conference in San Diego, Calif. (Booth #206 at the Hilton San Diego Bayfront Hotel).

"With BLItz, researchers will be able to perform specific protein quantitation, kinetics and affinity analyses of protein interactions with just a drop of sample in a simple 'drop, read, done' format at a price point below $20,000 per instrument," said Christopher Silva, ForteBio's vice president of marketing. "We believe BLItz will revolutionize the use of label-free protein analysis by making it more accessible than ever to individual bench scientists throughout the world. Ultimately, this will help to further drive basic research and biotherapeutic development."

Historically, label-free assays have been used selectively and relegated to institutions' core labs due to their high complexity and expense. This has traditionally produced bottlenecks in biotherapeutic research and development as scientists may wait days and weeks to schedule their experiments and then hours or longer to obtain results. BLItz is small – taking up less surface area than a tablet personal computer – so it can fit easily in an individual scientist's workspace and is simple to use. It requires only four microliters of sample – which is 15 to 20 times less volume than needed for traditional, SPR-based label-free assays or microplate-based ELISA assays. Additionally, its Dip and Read™ assays utilize disposable, ready-to-use biosensors to uniquely provide results in seconds to minutes.

BLItz utilizes the same BioLayer Interferometry (BLI) technology that powers ForteBio's flagship Octet® instrumentation platform, which enables real-time kinetics, affinity and quantitation measurements in high-throughput applications, with unprecedented ease of use and cost-efficiency.

"ForteBio has a history of delivering disruptive technologies that have re-invented the label-free protein analysis space," said Joseph D. Keegan, Ph.D., ForteBio's chief executive officer. "In just seven years, many leading academic, government and corporate institutions have adopted our Octet platform and have consumed more than four million biosensors for use on the system. We look forward to making similar inroads with our new BLItz platform and anticipate that BLItz will help fuel further growth in proteomics."

The new BLItz system is designed for any researcher working with proteins, particularly those who analyze column fractions, monitor protein expression, perform reagent QC, identify mechanism of action and signaling and run protein engineering studies.  More information about BLItz can be found at


ForteBio is a life science company that provides analytical systems to accelerate biotherapeutic drug discovery and development. These systems enable real-time, label-free analysis of biomolecular interactions, providing information on affinity, kinetics and concentration. ForteBio's analytical capabilities enable significantly easier, faster and better characterization of drug candidates, thus providing greater value in drug development applications where existing methods have limitations in throughput, performance and cost. The company is headquartered in Menlo Park, California, with wholly owned subsidiaries in London and Shanghai. For more information, visit

SOURCE ForteBio, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ForteBio Launches Dip and Read™ Anti-GST Biosensor
2. ForteBio Introduces New Biosensor for Kinetic Analysis and Screening of Mouse IgG Antibodies
3. ForteBio Launches New Octet® RED96 System and Dip and Read™ Protein L Biosensor
4. ForteBio Announces Launch of Protein G Biosensor for Use on Companys Octet® Instruments
5. ForteBio Launches New Dip and Read(TM) Residual Protein A Detection Kit; Introduces Sidekick(TM) Offline Biosensor Immobilization Station for All Octet(R) Instruments
6. Weld County Introduces Prescription Discount Card to Help Alleviate High Costs
7. Boston Scientific Introduces Industry-Leading ICD and CRT-D Device Warranties
8. Instrumentation Laboratory Introduces Automated HemosIL VWF Ristocetin Cofactor Activity Assay in Europe and International Regions
9. Hamamatsu Introduces the ORCA-Flash4.0 Scientific CMOS Camera With High Sensitivity, High Resolution, and Fast Readout
10. Omnicell Introduces Groundbreaking Mandarin-Language Medication Automation System for Use in Chinese Clinical Settings
11. Hologic Introduces Synthesized 2D Image Algorithm Designed to Eliminate the Need for a 2D Mammogram in a 2D plus 3D Tomosynthesis Exam
Post Your Comments:
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... June 23, 2016 Any dentist who has made ... the current process. Many of them do not even offer ... difficulties and high laboratory costs involved. And those who ARE ... at such a high cost that the majority of today,s ... Dr. Parsa Zadeh , founder of Dental Evolutions Inc. ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 Roche ... received 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) ... severe sepsis or septic shock. With this clearance, Roche ... provide a fully integrated solution for sepsis risk assessment ... associated with bacterial infection and PCT levels in blood ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can now ... and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings ... The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the ...
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/24/2016)... ... 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. ... the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has ... , Sickle Cell Disease (SCD) is a disorder of the red blood cells, which ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Investment Group (TGIG), has initiated cultivation and processing operations at its production facility, ... Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of proactive ...
Breaking Medicine News(10 mins):